Literature DB >> 11279144

FKBP12 binding modulates ryanodine receptor channel gating.

M Gaburjakova1, J Gaburjakova, S Reiken, F Huang, S O Marx, N Rosemblit, A R Marks.   

Abstract

The ryanodine receptor (RyR1)/calcium release channel on the sarcoplasmic reticulum of skeletal muscle is comprised of four 565,000-dalton RyR1s, each of which binds one FK506 binding protein (FKBP12). RyR1 is required for excitation-contraction coupling in skeletal muscle. FKBP12, a cis-trans peptidyl-prolyl isomerase, is required for the normal gating of the RyR1 channel. In the absence of FKBP12, RyR1 channels exhibit increased gating frequency, suggesting that FKBP12 "stabilizes" the channel in the open and closed states. We now show that substitution of a Gly, Glu, or Ile for Val2461 in RyR1 prevents FKBP12 binding to RyR1, resulting in channels with increased gating frequency. In the case of the V2461I mutant RyR1, normal channel function can be restored by adding FKBP12.6, an isoform of FKBP12. These data identify Val2461 as a critical residue required for FKBP12 binding to RyR1 and demonstrate the functional role for FKBP12 in the RyR1 channel complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279144     DOI: 10.1074/jbc.M100856200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Ablation of skeletal muscle triadin impairs FKBP12/RyR1 channel interactions essential for maintaining resting cytoplasmic Ca2+.

Authors:  Jose M Eltit; Wei Feng; Jose R Lopez; Isela T Padilla; Isaac N Pessah; Tadeusz F Molinski; Bradley R Fruen; Paul D Allen; Claudio F Perez
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling.

Authors:  Hua Wei; Xiao-Hua Zhang; Cassandra Clift; Naohiro Yamaguchi; Martin Morad
Journal:  Cell Calcium       Date:  2018-04-27       Impact factor: 6.817

Review 3.  Cross talk between Ca2+ and redox signalling cascades in muscle and neurons through the combined activation of ryanodine receptors/Ca2+ release channels.

Authors:  Cecilia Hidalgo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 4.  Ryanodine receptor structure: progress and challenges.

Authors:  Susan L Hamilton; Irina I Serysheva
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

5.  Architecture and conformational switch mechanism of the ryanodine receptor.

Authors:  Rouslan G Efremov; Alexander Leitner; Ruedi Aebersold; Stefan Raunser
Journal:  Nature       Date:  2014-12-01       Impact factor: 49.962

Review 6.  FK506-binding proteins 12 and 12.6 (FKBPs) as regulators of cardiac Ryanodine Receptors: Insights from new functional and structural knowledge.

Authors:  Luis A Gonano; Peter P Jones
Journal:  Channels (Austin)       Date:  2017-06-21       Impact factor: 2.581

7.  Extension of Health Span and Life Span in Drosophila by S107 Requires the calstabin Homologue FK506-BP2.

Authors:  Tabita Kreko-Pierce; Jorge Azpurua; Rebekah E Mahoney; Benjamin A Eaton
Journal:  J Biol Chem       Date:  2016-11-01       Impact factor: 5.157

Review 8.  Intracellular calcium release channels: an update.

Authors:  Gaetano Santulli; Ryutaro Nakashima; Qi Yuan; Andrew R Marks
Journal:  J Physiol       Date:  2017-05-15       Impact factor: 5.182

9.  N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.

Authors:  Tanya Girgenrath; Mohana Mahalingam; Bengt Svensson; Florentin R Nitu; Razvan L Cornea; James D Fessenden
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

10.  Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila.

Authors:  Reiko Sanokawa-Akakura; Weihuan Cao; Kirsten Allan; Khyati Patel; Anupama Ganesh; Gary Heiman; Richard Burke; Francis W Kemp; John D Bogden; James Camakaris; Raymond B Birge; Mary Konsolaki
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.